DQ 65–79, A Peptide Derived from HLA Class II, Mimics p21 to Block T Cell Proliferation 1

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Immunology

• Publication date

  2003-11-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.171.10.5064PMID 14607903
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DQ 65–79, a Peptide Derived from HLA Class II, Induces IκB Expression1

  2002cited by this paper
• DQ 65-79, a peptide derived from HLA class II, induces I kappa B expression.

  2002cited by this paper
• p21(WAF1/Cip1): more than a break to the cell cycle?

  2000influential reference
• Reversible Phosphorylation at the C-terminal Regulatory Domain of p21Waf1/Cip1 Modulates Proliferating Cell Nuclear Antigen Binding*

  2000cited by this paper
• A Direct Interaction between Proliferating Cell Nuclear Antigen (PCNA) and Cdk2 Targets PCNA-interacting Proteins for Phosphorylation*

  2000cited by this paper
• Intranuclear localization of proliferating cell nuclear antigen during the cell cycle in renal cell carcinoma.

  2000cited by this paper
• A human class II MHC-derived peptide antagonizes phosphatidylinositol 3-kinase to block IL-2 signaling.

  2000cited by this paper
• Characterization of MyD118, Gadd45, and Proliferating Cell Nuclear Antigen (PCNA) Interacting Domains

  2000cited by this paper
• A quantitative study of the in vitro binding of the C-terminal domain of p21 to PCNA: affinity, stoichiometry, and thermodynamics.

  2000cited by this paper
• Proliferating Cell Nuclear Antigen as the Cell Cycle Sensor for an HLA-Derived Peptide Blocking T Cell Proliferation1

  2000cited by this paper
• PCNA binding proteins.

  1999cited by this paper
• The C-terminal domain of p21 inhibits nucleotide excision repair In vitro and In vivo.

  1999cited by this paper
• Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis.

  1999cited by this paper
• A p21(Waf1/Cip1)carboxyl-terminal peptide exhibited cyclin-dependent kinase-inhibitory activity and cytotoxicity when introduced into human cells.

  1999cited by this paper
• HLA-derived peptides as novel immunomodulatory therapeutics.

  1999cited by this paper
• Protein-PCNA interactions: a DNA-scanning mechanism?

  1998cited by this paper
• Inhibition of cell cycle progression by a synthetic peptide corresponding to residues 65-79 of an HLA class II sequence: functional similarities but mechanistic differences with the immunosuppressive drug rapamycin.

  1998cited by this paper
• Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen.

  1998cited by this paper
• p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells

  1998cited by this paper
• PCNA, a multifunctional ring on DNA.

  1998cited by this paper
• p21WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth.

  1997cited by this paper
• Cyclin-dependent kinases: engines, clocks, and microprocessors.

  1997cited by this paper
• Homologous regions of Fen1 and p21Cip1 compete for binding to the same site on PCNA: a potential mechanism to co-ordinate DNA replication and repair

  1997cited by this paper
• Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21WAF1.

  1997cited by this paper
• PCNA: structure, functions and interactions

  1997cited by this paper
• Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1.

  1997cited by this paper
• Structure of the C-terminal region of p21(WAF1/CIP1) complexed with human PCNA.

  1996cited by this paper
• Structure of the C-Terminal Region of p21 Complexed with Human PCNA

  1996influential reference
• Cyclin-binding motifs are essential for the function of p21CIP1

  1996cited by this paper
• Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors

  1996cited by this paper
• A 39 amino acid fragment of the cell cycle regulator p21 is sufficient to bind PCNA and partially inhibit DNA replication in vivo.

  1996cited by this paper
• Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor.

  1995cited by this paper
• The C-terminal Region of p21 Is Involved in Proliferating Cell Nuclear Antigen Binding but Does Not Appear to Be Required for Growth Inhibition (*)

  1995cited by this paper
• Inhibition of Nucleotide Excision Repair by the Cyclin-dependent Kinase Inhibitor p21 (*)

  1995cited by this paper
• Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21.

  1995cited by this paper
• Inhibition of the alloimmune response with synthetic nonpolymorphic class II MHC peptides.

  1995cited by this paper
• Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA

  1995cited by this paper
• A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen.

  1995cited by this paper
• Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme.

  1994cited by this paper
• D-type cyclin-binding regions of proliferating cell nuclear antigen.

  1994cited by this paper
• Immunity to MHC class I antigen after direct DNA transfer into skeletal muscle.

  1994cited by this paper
• The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA

  1994cited by this paper
• Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen.

  1994cited by this paper
• Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen.

  1994cited by this paper
• Induction of allograft tolerance in rats by an HLA class-I-derived peptide and cyclosporine A.

  1994cited by this paper
• Nuclear distribution of proliferating cell nuclear antigen (PCNA) in fertilized eggs of the starfish Asterina pectinifera.

  1994cited by this paper
• The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

  1993cited by this paper
• Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit

  1993cited by this paper
• p21 is a universal inhibitor of cyclin kinases

  1993cited by this paper
• Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes.

  1993cited by this paper
• Induction of specific unresponsiveness using transfected cells expressing donor major histocompatibility complex molecules: evidence for indirect presentation of allopeptides in vivo.

  1993cited by this paper
• Peptides corresponding to T-cell receptor-HLA contact regions inhibit class I-restricted immune responses.

  1993cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• Regulation of proliferating cell nuclear antigen during the cell cycle.

  1989cited by this paper
• Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes

  1988cited by this paper
• Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the α2 domain of HLA–A2

  1987cited by this paper
• Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the alpha 2 domain of HLA-A2.

  1987cited by this paper
• HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes

  1987cited by this paper
• Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+.

  1982cited by this paper

• Targeting Proliferating Cell Nuclear Antigen (PCNA) as an Effective Strategy to Inhibit Tumor Cell Proliferation.

  2020cites this paper
• Polymer Cancerostatics Containing Cell-Penetrating Peptides: Internalization Efficacy Depends on Peptide Type and Spacer Length

  2020influential citation
• Cell-penetrating peptides: a useful tool for the delivery of various cargoes into cells.

  2018cites this paper
• Rôles du Proliferating Cell Nuclear Antigen et de p21/waf1, protéines régulatrices du cycle cellulaire dans l'apoptose du polynucléaire neutrophile : Intérêt potentiel dans la modulation de l'inflammation

  2013cites this paper
• The latest developments in synthetic peptides with immunoregulatory activities.

  2011cites this paper
• Proliferating cell nuclear antigen acts as a cytoplasmic platform controlling human neutrophil survival

  2010cites this paper
• Protection of Murine Systemic Lupus by the Ea Transgene without Expression of I-E Heterodimers1

  2008cites this paper
• DQA1*03011 allele: protective or an adverse effect on the development of sarcoidosis; preliminary study.

  2007cites this paper
• A novel apoptosis pathway activated by the carboxyl terminus of p21.

  2005influential citation
• MHC Class II – Mediated Apoptosis by a Nonpolymorphic MHC Class II Peptide Proceeds by Activation of Protein Kinase

  2005cites this paper
• Peptide-mediated immunosuppression.

  2005cites this paper
• MHC Class II-mediated apoptosis by a nonpolymorphic MHC Class II peptide proceeds by activation of protein kinase C.

  2005cites this paper